Total Payments
$14,185
2024 Payments
$1,661
Companies
47
Transactions
844
Medicare Patients
10,041
Medicare Billing
$787,720
Payment Breakdown by Category
Food & Beverage$14,139 (99.7%)
Education$31.03 (0.2%)
Other$15.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,139 | 838 | 99.7% |
| Education | $31.03 | 5 | 0.2% |
| Honoraria | $15.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,079 | 102 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,317 | 72 | $0 (2024) |
| Novo Nordisk Inc | $1,026 | 70 | $0 (2024) |
| Lilly USA, LLC | $912.71 | 72 | $0 (2024) |
| PFIZER INC. | $812.40 | 66 | $0 (2024) |
| Merck Sharp & Dohme LLC | $707.91 | 45 | $0 (2023) |
| Mylan Specialty L.P. | $606.89 | 38 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $600.00 | 3 | $0 (2021) |
| Astellas Pharma US Inc | $560.40 | 31 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $539.86 | 32 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,661 | 87 | AstraZeneca Pharmaceuticals LP ($433.59) |
| 2023 | $1,318 | 68 | AstraZeneca Pharmaceuticals LP ($250.94) |
| 2022 | $1,749 | 97 | Boehringer Ingelheim Pharmaceuticals, Inc. ($192.26) |
| 2021 | $2,313 | 128 | MERZ NORTH AMERICA, INC. ($300.00) |
| 2020 | $2,167 | 121 | AstraZeneca Pharmaceuticals LP ($268.91) |
| 2019 | $1,630 | 98 | AstraZeneca Pharmaceuticals LP ($320.90) |
| 2018 | $1,685 | 126 | AstraZeneca Pharmaceuticals LP ($269.36) |
| 2017 | $1,663 | 119 | Boehringer Ingelheim Pharmaceuticals, Inc. ($276.30) |
All Payment Transactions
844 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Biological | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: Obesity | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Biological | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Bone Health | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: UROLOGY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Gastroenterology | ||||||
| 09/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $29.87 | General |
| Category: Cardiovascular | ||||||
| 08/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,533 | 4,265 | $522,910 | $224,703 |
| 2022 | 22 | 2,611 | 4,447 | $512,720 | $207,036 |
| 2021 | 21 | 2,427 | 4,273 | $499,770 | $191,767 |
| 2020 | 27 | 2,470 | 4,172 | $467,493 | $164,214 |
Total Patients
10,041
Total Services
17,157
Medicare Billing
$787,720
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 396 | 824 | $185,400 | $75,000 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 449 | 932 | $139,800 | $51,515 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 266 | 266 | $53,200 | $35,477 | 66.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 79 | 125 | $21,875 | $10,379 | 47.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 136 | 136 | $10,200 | $9,782 | 95.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 448 | 1,008 | $25,200 | $8,459 | 33.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 26 | 91 | $13,650 | $6,813 | 49.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 136 | 136 | $4,760 | $4,359 | 91.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 52 | $7,800 | $4,344 | 55.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 15 | $4,125 | $3,234 | 78.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 297 | 320 | $17,600 | $2,941 | 16.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 38 | 50 | $3,750 | $2,410 | 64.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,225 | $2,209 | 42.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 41 | 46 | $5,750 | $1,654 | 28.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 16 | 17 | $9,350 | $1,632 | 17.5% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 12 | 14 | $3,850 | $1,533 | 39.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $1,925 | $1,509 | 78.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 70 | $3,500 | $723.07 | 20.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $3,150 | $298.02 | 9.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 60 | 85 | $2,125 | $289.85 | 13.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 22 | 27 | $675.00 | $139.90 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 452 | 1,092 | $163,800 | $66,492 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 323 | 566 | $127,350 | $47,180 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 289 | 289 | $57,800 | $39,565 | 68.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 132 | 133 | $9,975 | $9,106 | 91.3% |
About Dr. John Deforest, D.O
Dr. John Deforest, D.O is a Family Medicine healthcare provider based in Beecher, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003842964.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Deforest, D.O has received a total of $14,185 in payments from pharmaceutical and medical device companies, with $1,661 received in 2024. These payments were reported across 844 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($14,139).
As a Medicare-enrolled provider, Deforest has provided services to 10,041 Medicare beneficiaries, totaling 17,157 services with total Medicare billing of $787,720. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Beecher, IL
- Active Since 06/23/2006
- Last Updated 12/09/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1003842964
Products in Payments
- FARXIGA (Drug) $1,471
- JARDIANCE (Drug) $497.63
- XARELTO (Drug) $496.53
- STIOLTO RESPIMAT (Drug) $472.88
- TRULICITY (Drug) $447.22
- Ozempic (Drug) $388.67
- Yupelri (Drug) $349.53
- ELIQUIS (Drug) $319.93
- GEMTESA (Drug) $311.14
- EVENITY (Biological) $307.64
- XEOMIN (Biological) $300.00
- JANUVIA (Drug) $296.39
- NEXLETOL (Drug) $289.01
- TRELEGY ELLIPTA (Drug) $272.52
- XIFAXAN (Drug) $264.22
- MYRBETRIQ (Drug) $260.81
- CHANTIX (Drug) $259.23
- TRADJENTA (Drug) $238.30
- BELSOMRA (Drug) $236.87
- SYMBICORT (Drug) $234.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.